SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ:EXEL) today announced its slate of activities in conjunction with the 2011 American Society of Clinical Oncology (ASCO) Annual ...